HOME >> BIOLOGY >> NEWS
Biotech Foods Ready For Primetime, Experts Say

WEST LAFAYETTE, Ind. -- For many of your favorite foods, the future has arrived.

Genetic engineering, long the focus of anticipation and discussion in American agriculture, entered the realm of reality in a big way in 1998. The fact is that if in the past year you've topped a sandwich with cheese, gobbled down a bowl of cereal, or guzzled a soft drink, chances are that you've eaten foods from genetically modified crops.

Although people in agriculture have been heralding the promise of genetically enhanced crops for 20 years, few products made it to market. Quietly, over the past three years, that has changed in a major way. Marshall Martin, professor of agricultural economics and director of Purdue University's Center for Agricultural Policy and Technology Assessment, says that many common foods now use biotechnology in their production and processing.

"The genetically engineered enzyme chymosin is used in two-thirds to three-quarters of the cheese produced," Martin says. "Bt-corn, which allows the corn plants to resist the corn borer, has found wide acceptance. So everyone is already eating foods produced through biotechnology."

In fact, the use of genetically enhanced corn has increased from 400,000 acres in 1996 to three million acres in 1997 to an estimated 17 million acres planted in 1998. Each year, total corn acreage in the United States is about 80 million acres.

Biotechnology is used to produce some of our most common foods:

  • Corn produced through biotechnology is being used in many familiar foods, including breakfast cereals and taco shells. It also is used to make corn syrup, which is used as a sweetener in many foods such as soft drinks, baked goods and candies.
  • Soybeans are used in hundreds of food products, including cooking oil, candies and margarine. In 1997, about 20 million acres of the soybeans planted in the United States were genetically enhanced. Pr
    '"/>


Contact: Steve Tally
tally@aes.purdue.edu
765-494-9809
Purdue University
10-Sep-1998


Page: 1 2 3

Related biology news :

1. Nanosphere announces genetic detection advance in Nature Biotechnology
2. Leroy Hood to receive 2004 Biotechnology Heritage Award
3. Christopher Walsh wins 2004 Promega Biotechnology Research Award
4. Advancing Biotechnology Breakthroughs
5. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
6. Quark Biotech generates a cholesterol-free mouse
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech Foods Ready For Primetime Experts Say

(Date:12/19/2014)... VIEW, Calif. , Dec. 18, 2014  23andMe, ... publication of a study that pinpoints fine-scale differences in ... United States . Since immigrants first ... the United States has served as a ... illuminates how American history and the ongoing mixing of ...
(Date:12/17/2014)... , Dec. 15, 2014 The Defense ... it easier to detect and prevent counterfeit microcircuits ... Today the agency started performing an in-house microcircuit ... validate the authenticity of purchased microcircuits while increasing ... quality control measures will be conducted at DLA,s ...
(Date:12/17/2014)... 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend ... for medical sensors in biomedical applications. Chemical sensors ... and correct diagnosis during surgical procedures. The Global ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Achim Noack ... administration for Stoller Group. In this position, Noack will ... on administrative matters, develop marketing strategy and supervise global ... , “Achim has tremendous knowledge and experience in ... Stoller Group. “His experience and innovative thinking will be ...
(Date:12/17/2014)... This report is a professional and ... an overview analysis, the report introduces quartz tubing ... industry overview, policy analysis, and news analysis, etc. ... witnessed rapid development with key manufacturers increasing their ... mentions quartz tubing upstream raw materials and equipment, ...
(Date:12/17/2014)... San Diego, CA (PRWEB) December 17, 2014 ... strategy and activation agency and member of the Huntsworth ... Jamie Gonzales to its executive team. In her role, ... Services. , “We are incredibly honored to welcome ... said Agency Chief and CEO, Gaëtan Fraikin. “She is ...
(Date:12/17/2014)... CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... primary commercial focus on China , ... C meeting with the U.S. Food and Drug Administration ... February 2015.  During this meeting the Company will seek ...
Breaking Biology Technology:Achim Noack Joins Stoller Group as Global Vice President of Marketing and Administration 22020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
Cached News: